This Article Free upon publication Full Text (PDF) Correction (v119,pe605) All Versions of this Article: 119/2/351    most recent CIRCULATIONAHA.108.191305v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Skyler, J. S. Articles by Sherwin, R. S. Search for Related Content PubMed PubMed Citation Articles by Skyler, J. S. Articles by Sherwin, R. S. Related Collections Type 1 diabetes Type 2 diabetes

Submitted on ,
Accepted on ,

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

From the University of Miami, Miami, Fla (J.S.S.); International Diabetes Center at Park Nicollet, Minneapolis, Minn (R.B.); Northwestern University Feinberg School of Medicine, Chicago, Ill (R.O.B.); University of North Carolina, Chapel Hill (J.B.); VA Central California Healthcare System, University of California San Francisco, Fresno (P.D.); University of Bristol, Bristol, UK (E.A.M.G., B.V.H.); MedStar Research Institute, Hyattsville, Md (B.V.H.); American Diabetes Association, Alexandria, Va (M.S.K.); Mid America Heart Institute of Saint Luke's Hospital and University of Missouri–Kansas City, Kansas City (M.K.); Carl T. Hayden VA Medical Center, Phoenix, Ariz (P.R.); and Yale University School of Medicine, New Haven, Conn (R.S.S.).

^* To whom correspondence should be addressed. E-mail: skirkman{at}diabetes.org.

This article has been cited by other articles:

				S. R. Preis, M. J. Pencina, S.-J. Hwang, R. B. D'Agostino Sr, P. J. Savage, D. Levy, and C. S. Fox Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study Circulation, July 21, 2009; 120(3): 212 - 220. [Abstract] [Full Text] [PDF]

				J. Wilding Results of the LEAD-2 study in relation to NICE and ADA/EASD guidelines for the treatment of type 2 diabetes in the UK The British Journal of Diabetes & Vascular Disease, July 1, 2009; 9(4): 177 - 185. [Abstract] [PDF]

				B. Hemmingsen, S. S Lund, J. Wetterslev, and A. Vaag Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes Eur. J. Endocrinol., July 1, 2009; 161(1): 1 - 9. [Abstract] [Full Text] [PDF]

				The BARI 2D Study Group A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease N. Engl. J. Med., June 11, 2009; 360(24): 2503 - 2515. [Abstract] [Full Text] [PDF]

				R. A. Whitmer, A. J. Karter, K. Yaffe, C. P. Quesenberry Jr, and J. V. Selby Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus JAMA, April 15, 2009; 301(15): 1565 - 1572. [Abstract] [Full Text] [PDF]